SEC Form 4 · accession 0001144204-15-019369
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon A Troup
Director
Period of report
Mar 26, 2015
Accepted (ET)
Mar 30, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 26, 2015 | A | 22,000 | $0.00 | A | 211,755 | D |
Table II — derivative securities
No Table II lines on this filing.